logo
Sign in

HUMAW Stock Price, Chart, Stats & News

Humacyte, Inc.
Save
8.43M
Market cap
Current P/E
Forward P/E

HUMAW chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
-134.49%
Operating margin
-5306.04%
Pretax margin
-786.51%
Net margin
-2003.58%
Effective tax rate
ROA
-35.09%
ROE
-424.76%
D/E
20.86x
Interest coverage ratio
-21.64x

HUMAW valuation

P/E
P/S
51.97x
P/B
34.37x
P/CF
-1.02x
P/FCF
-1.00x
P/OCF
-1.02x
PEG
-0.60x
EV multiple
-2.76x

About

Humacyte, Inc. is a company dedicated to the creation and production of bioengineered human tissues that are readily available and suitable for implantation. These advanced tissues are intended for the treatment of a variety of diseases and medical conditions, applicable to numerous anatomical sites and therapeutic areas. The company employs its distinct, proprietary scientific platform to engineer and manufacture human acellular vessels (HAVs).

Similar securities

Based on sector and market capitalization

Report issue